Literature DB >> 26916294

Melatonin does not affect disseminated intravascular coagulation but diminishes decreases in platelet count during subacute endotoxaemia in rats.

Maren Oude Lansink1, Klaus Görlinger2, Matthias Hartmann3, Herbert de Groot1, Katharina Effenberger-Neidnicht4.   

Abstract

INTRODUCTION: Inhibitory effects of exogenous melatonin (MLT) on plasma coagulation and platelet aggregation have already been observed in vivo and in vitro under normal conditions. Here, we studied whether MLT also diminishes the lipopolysaccharide (LPS)-induced disseminated intravascular coagulation (DIC) during subacute endotoxaemia.
MATERIALS AND METHODS: Subacute endotoxaemia was induced in male Wistar rats by an intravenous infusion of LPS over a period of 300min (0.5mg LPS/kg×h). MLT was administered intravenously 15min before and 120min and 240min after starting of the LPS infusion (3×3mg MLT/kg×15min). The kinetic of clot formation was analysed by thromboelastometry.
RESULTS: Infusion of LPS led initially to a significant reduction of clotting time (120min, LPS: 150±21s vs. SHAM: 292±36s), and finally a significant increase of clotting time (300min, LPS: 2768±853s vs. SHAM: 299±67s) and a slight increase of clot formation time (300min, LPS: 1038±657s vs. SHAM: 98±14s) as well as a significant decrease of alpha-angle (300min, LPS: 35±15° vs. SHAM: 72±3°), maximum clot firmness (300min, LPS: 22±6mm vs. SHAM: 68±3mm), and area under the curve (300min, LPS: 1657±552mm×100 vs. SHAM: 6849±307mm×100). Simultaneously, a decrease of platelet count (300min, LPS: 55±8 vs. SHAM: 180±55) and a release of cell-free haemoglobin (240min, LPS: 46±5μmol/L vs. SHAM: 16±2μmol/L) could be observed in the course of subacute endotoxaemia. The additional administration of MLT did not reduce the LPS-induced alterations in parameters of thromboelastometry, but significantly reduced the LPS-induced decrease of platelet count (300min, LPS+MLT: 130±10) and release of cell-free haemoglobin (240min, LPS+MLT: 29±3μmol/L).
CONCLUSION: Melatonin does not affect DIC but diminishes thrombocytopenia and haemolysis during endotoxaemia.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hemolysis; Lipopolysaccharide; Platelet; Sepsis; Thromboelastometry

Mesh:

Substances:

Year:  2015        PMID: 26916294     DOI: 10.1016/j.thromres.2015.10.025

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

Review 1.  Mechanisms of Hemolysis During Sepsis.

Authors:  Katharina Effenberger-Neidnicht; Matthias Hartmann
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

2.  Administration of Exogenous Melatonin After the Onset of Systemic Inflammation Is Hardly Beneficial.

Authors:  Lisa Brencher; Maren Oude Lansink; Katharina Effenberger-Neidnicht
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

Review 3.  Melatonin effect on platelets and coagulation: Implications for a prophylactic indication in COVID-19.

Authors:  Azam Hosseinzadeh; Abolfazl Bagherifard; Fereshteh Koosha; Shiva Amiri; Arman Karimi-Behnagh; Russel J Reiter; Saeed Mehrzadi
Journal:  Life Sci       Date:  2022-08-06       Impact factor: 6.780

4.  Moderate glucose supply reduces hemolysis during systemic inflammation.

Authors:  Johannes Jägers; Stephan Brauckmann; Michael Kirsch; Katharina Effenberger-Neidnicht
Journal:  J Inflamm Res       Date:  2018-03-12

Review 5.  Cardioprotective Role of Melatonin in Acute Myocardial Infarction.

Authors:  Zhenhong Fu; Yang Jiao; Jihang Wang; Ying Zhang; Mingzhi Shen; Russel J Reiter; Qing Xi; Yundai Chen
Journal:  Front Physiol       Date:  2020-04-29       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.